Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose

Molecular Carcinogenesis

Volumn 47, Issue 8, 2008, Pages 616-628

  Jiang, Weiqin ^a   Zhu, Zongjian ^a   Thompson, Henry J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

2 deoxyglucose; AMP activated protein kinase; Energy availability; Mammalian target of rapamycin; Protein kinase B

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATE; BINDING PROTEIN; DEOXYGLUCOSE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 4E; MAMMALIAN TARGET OF RAPAMYCIN; METHYLNITROSOUREA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P110; S6 KINASE; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL LINE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DEOXYGLUCOSE; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EUKARYOTA; MAMMALIA; RATTUS;

EID: 48149109621     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20425     Document Type: Article

References (45)

1. Warburg O. The metabolism of tumors. London: Constable; 1930.
2. Pan JG, Mak TW. Metabolic targeting as an anticancer strategy: Dawn of a new era? Sci STKE 2007;pe14:1-4.
3. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
4. Kim Jw, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006;66:8927-8930.
5. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene 2006;25:4675-4682.
6. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005;7:77-85.
7. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9: 425-434.
8. Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: Potential impact on invasiveness. J Theor Biol 2007;244:703-713.
9. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-899.
10. Thompson CB, Bauer DE, Lum JJ, et al. How do cancer cells acquire the fuel needed to support cell growth? Cold Spring Harb. Symp Quant Biol 2005;70:357-362.
11. Birt DF, Copenhaver J, Barnett T, Pelling JC, Luthra R. Dietary fat and energy modulation of biochemical events in tumor promotion. Adv Exp Med Biol 1997;400B:925-929.
12. Dirx MJ, Zeegers MP, Dagnelie PC, van den BT, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis. Int J Cancer 2003;106:766-770.
13. Hursting SD, Perkins SN, Phang JM, Barrett JC. Diet and cancer prevention studies in p53-deficient mice. J Nutr 2001; 131:3092S-3094S.
14. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 2002;21:147-151.
15. Mai V, Colbert LH, Berrigan D, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res 2003;63:1752-1755.
16. Zhu Z, Haegele AD, Thompson HJ. Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 1997;18:1007-1012.
17. Zhu Z, Jiang W, McGinley JN, Thompson HJ. 2-Deoxyglucose as an energy restriction mimetic agent: Effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res 2005;65:7023-7030.
18. Sols A, Crane RK. The inhibition of brain hexokinase by adenosinediphosphate and sulfhydryl reagents. J Biol Chem 1954;206:925-936.
19. Tower DB. The effects of 2-deoxy-D-glucose on metabolism of slices of cerebral cortex incubated in vitro. J Neurochem 1958;3:185-205.
20. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 1997;246: 259-273.
21. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002;277: 23977-23980.
22. Kimura N, Tokunaga C, Dalal S, et al. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 2003;8:65-79.
23. Krause U, Bertrand L, Hue L. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur J Biochem 2002;269:3751-3759.
24. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 2001;294:1942-1945.
25. Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 1999;344:427-431.
26. Peterson RT, Beal PA, Comb MJ, Schreiber SL. FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 2000;275:7416-7423.
27. Gerasimovskaya EV, Tucker DA, Weiser-Evans M, et al. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways. J Biol Chem 2005;280:1838-1848.
28. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005;14:R251-R258.
29. Yin W, Mu J, Birnbaum MJ. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes. J Biol Chem 2003;278:43074-43080.
30. Jiang W, Zhu Z, Thompson HJ. Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats. Cancer Res 2003;63:1228-1234.
31. Snedecor GW, Cochran WG. Statistical methods, 8th edition. Ames, IA: Iowa State University Press; 1989. 503 p.
32. Conover WJ. Practical nonparametric statisitics. New York: John Wiley & Sons; 1980.
33. Sokal RR, Rohlf FJ. Biometry: The principles and practice of statistics in biological research, 3rd edition. New York: W.H. Freeman; 1995.
34. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003;115: 577-590.
35. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 1998;12:502-513.
36. Martin KA, Blenis J. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv Cancer Res 2002; 86:1-39.
37. Martin KA, Rzucidlo EM, Merenick BL, et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 2004;286:C507-C517.
38. Lee CC, Huang CC, Wu MY, Hsu KS. Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J Biol Chem 2005;280:18543-18550.
39. Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001;15:807-826.
40. Sonenberg N, Gingras AC. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr Opin Cell Biol 1998;10:268-275.
41. Scott JW, Norman DG, Hawley SA, Kontogiannis L, Hardie DG. Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate. J Mol Biol 2002;317:309-323.
42. Viollet B, Andreelli F, Jorgensen SB, et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 2003;111:97 -98.
43. Zhu Z, Jiang W, Thompson HJ. An experimental paradigm for studying the cellular and molecular mecnanisms of cancer inhibition by energy restriction. Mol Carcinog 2002;35:51-56.
44. Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 2003;107:873-877.
45. Halse R, Rochford JJ, McCormack JG, Vandenheede JR, Hemmings BA, Yeaman SJ. Control of glycogen synthesis in cultured human muscle cells. J Biol Chem 1999;274:776-780.